Enhancing the reputation of the pharmaceutical industry, improving access to innovative medicines for NHS patients and ensuring a UK environment that enables the Life Sciences industry to thrive are the three key priorities for Lisa Anson as she begins her two-year Presidency of the Association of...
The Association of the British Pharmaceutical Industry (ABPI) have responded to an announcement made today by Health Minister Lord O’Shaughnessy to spend £86 million "to help develop real world medical breakthroughs that will help patients across the NHS."
Dr Sheuli Porkess, ABPI's Head of Medical Affairs, says:
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...
Following publication of ‘The United Kingdom’s Exit from, and New Partnership with, the European Union’ White Paper, the Association of the British Pharmaceutical Industry (ABPI) has issued the following statement.
The Association of the British Pharmaceutical Industry (ABPI) has responded to today’s triggering of Article 50 of the Lisbon Treaty by Prime Minister Theresa May, officially starting the process of the United Kingdom (UK) negotiating its departure from the European Union (EU).
This week, the House of Lords Science and Technology Committee published a report into the Life Sciences Industrial Strategy, asking: "Who's Driving the Bus?"
This week, the Kings Fund published a new report into the cost of medicines looking at how much the health service spends in total on medicines; both generics and branded medicines.
What will the future of medicine look like? A new virtual reality experience from the Association of the British Pharmaceutical Industry explores futuristic treatments and technologies like inhalable nanobots and 3D printed medicine patches, already being researched by companies and which rival Sci-...
The Association of the British Pharmaceutical Industry (ABPI) has responded to today's publication of the Exiting the EU Committee report into the process for exiting the European Union and the Government's negotiating objectives.